In Alzheimer’s disease, it has been shown that increased Fyn kinase activity correlates with altered tyrosine phosphorylation of the NR2B subunit of NMDAR, which, in turn, modulates its gating properties, leading to abnormal synaptic function and neuronal loss [69]. Here, GRIN2B is linked to Alzheimer disease.